• Appistry’s Vision for Clinical Lab Analysis

    Bio-IT World | Appistry launches managed services for clinical sequencing, incorporating GenomePilot, and covering the entire pipeline from when data comes off the sequencers to results analysis.

    Jul 14, 2016

  • With new owner the hated impact factor is overdue for change

    STAT | The impact factor is a poor measure of a journal's quality, and academics say it should either be overhauled or done away with entirely.

    Jul 14, 2016

  • Wellcome Trust launches open-access publishing venture

    Nature News & Comment | Wellcome Open Research is meant to allow Wellcome grant recipients to publish their findings more quickly. The charity hopes other funders will follow a similar model. Management of the venture will be contracted to F1000Research.

    Jul 13, 2016

  • Genomic Medicine Training, New Storage Options, Food Allergy Science

    Bio-IT World | News and product launches from around the Bio-IT landscape include a postdoctoral fellowship in genomics medicine in Alabama, a synthetic biology partnership, new Lustre storage, and the Broad's food allergy science institute.

    Jul 12, 2016

  • A Drug For Postpartum Depression? Sage Passes Early Test With Experimental Treatment

    Forbes | Encouraging news is out today for the treatment of severe postpartum depression. Sage Therapeutics, a biotech company in Cambridge, Mass., reported that its experimental drug was able to relieve severe symptoms of postpartum depression for 70% of patients within a few days, and keep them in remission for a month.

    Jul 12, 2016

  • Intel's Cancer Cloud: Complementing NCI Collaboration

    Bio-IT World | Intel may have missed out on a major government grant, but that hasn't stopped it from developing a collaborative cloud for genomicists and bioinformaticians that it wanted to build all along.

    Jul 11, 2016

  • IT spending will shrink worldwide due to Brexit Gartner predicts

    Computerworld | Britain's vote to exit the European Union will depress global IT spending, according to Gartner analyst John-David Lovelock.

    Jul 8, 2016

  • Juno Therapeutics Stops Trial Of Cancer-Killing Cells After 3 Patient Deaths

    Forbes | Three patients have died in a closely watched study of using genetically engineered white blood cells to treat adult leukemia patients, forcing the trial to be put on hold. The news is a blow for Juno Therapeutics, the biotechnology startup valued at $4.3 billion.

    Jul 8, 2016

  • Obama Seeks To Make Mark On Genetic Medicine

    Forbes | After a few weeks of hype around the Obama administration's efforts to speed cancer research, officials tonight announced plans to kickstart efforts around the president's Precision Medicine Initiative.

    Jul 7, 2016

  • Cloud Adoption Numbers Are All Over the Map

    Fortune | Johnson & Johnson turned off its last mainframe and plans to move 85% of its software to the cloud. Is it mainstream or an outlier?

    Jul 7, 2016

  • Pfizer Might Buy Bind Therapeutics From Bankruptcy for $20M

    Xconomy | Bind Therapeutics and its treatment for treatment for non-small cell lung cancer may soon be owned by one-time partner Pfizer. Bind, which filed for Chapter 11 bankruptcy in May asked the court to approve a bid from Pfizer on July 1.

    Jul 6, 2016

  • Owning Your Data: The Genos Model

    Bio-IT World | Consumer genomics startup, Genos, is expanding its beta program and inviting Bio-IT World readers to sequence their whole exome at CLIA-certified 75x coverage for $399.

    Jul 5, 2016

  • Building Amgen’s RWD Platform

    Bio-IT World | Best Practices Amgen built a Real World Data platform to provide an enterprise-wide capability to better access and analyze available claims, electronic health records (EHRs), and cohort data, and address questions across the clinical and health IT development lifecycle.

    Jul 1, 2016